PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum

Neuropsychopharmacology

Volumn 21, Issue 6, 1999, Pages 694-709

  Drevets, Wayne C ^a   Price, Julie C ^a   Kupfer, David J ^a   Kinahan, Paul E ^a   Lopresti, Brian ^a   Holt, Daniel ^a   Mathis, Chester ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Accumbens; Caudate; Dopamine; Mesolimbic; Positron emission tomography (PET); Striatum

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG BINDING; FEMALE; IMAGE ANALYSIS; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN;

AMPHETAMINE; ANIMALS; CARBON RADIOISOTOPES; CAUDATE NUCLEUS; CORPUS STRIATUM; DOPAMINE; FEMALE; MAGNETIC RESONANCE IMAGING; MALE; NUCLEUS ACCUMBENS; PAPIO; PUTAMEN; RACLOPRIDE; RATS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032794485     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00079-2     Document Type: Article

References (69)

1. Alheid G.F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders. The striatopallidal, amygdaloid, and corticopetal components of substantia innominata Neuroscience. 27:1988;1-39.
2. Black K.J., Gado M.H., Videen T.O., Perlmutter J.S. Baboon basal ganglia stereotaxy using internal MRI landmarks. Validation and application to PET imaging J Comput Assist Tomogr. 21(6):1997;881-886.
3. Brazell M.P., Mitchell S.N., Joseph M.H., Gray J.A. Acute administration of nicotine increases the in vivo extracellular levels of DA, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat. Comparison with caudate-putamen Neuropsychopharmacology. 29:1990;1177-1185.
4. Breier A., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations. Evidence from a novel positron emission tomography method Proc Natl Acad Sci USA. 94:1997;2569-2574.
5. Brix G., Zaers J., Adam L.-E., Belleman M.E., Ostertag H., Trojan H., Haberkorm U., Doll J., Oberdofer F., Lorenz W.J. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nuc Med. 38:1997;1614-1623.
6. 3H]dopamine binding associated with dopamine release in calf brain membranes. Mol Pharmacol. 12:1976;800-812.
7. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine, and nomifensine increase extracellular DA concentrations preferentially in nucleus accumbens of freely moving rats. Neurosceince. 28:1989;653-661.
8. 11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab. 17:1997;437-447.
9. Deutch A.Y. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits. Implications for schizophrenia and Parkinson's disease J Neural Transm. 91:1993;197-221.
10. 11C-raclopride and positron emission tomography. J Neurosci. 12(10):1992;3773-3780.
11. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse. 13:1993;350-356.
12. Di Chiara G. On the preferential release of mesolimbic dopamine by amphetamine. Neuropsychopharmacology. 5:1991;243-244.
13. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 85:1988;5274-5278. a.
14. Di Chiara G., Imperato A. Opposite effects of μ and κ-opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther. 244:1988;1067-1080. b.
15. Di Chiara G., Tanda G., Frau R., Carboni E. On the preferential release of dopamine in the nucleus accumbens by amphetamine. further evidence obtained by vertically implanted concentric dialysis probes Psychopharmacology. 112:1993;398-402.
16. 11C]raclopride. Combined PET-Microdialysis studies J Cereb Blood Flow Metab. 17:1997;932-942.
17. Everitt B.J., Cador M., Robbins T.W. Interactions between the amygdala and ventral striatum in stimulus-reward associations. Studies using a second-order schedule of sexual reinforcement Neuroscience. 30:1989;63-75.
18. Fibiger H.C. The dopamine hypotheses of schizophrenia and mood disorders. Willner P., Scheel-Kruger J. The Mesolimbic Dopamine System. From Motivation to Action:1991;615-638 Wiley, New York.
19. Fox P.T., Mintun M.A., Raichle M.E., Miezin F.M., Allman J.M., Van Essen D.C. Mapping human visual cortex with positron emission tomography. Nature. 30:1986;806-809.
20. Gerfen C.R., Baimbridge K.J., Miller J.J. The neostriatal mosaic. Compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey Proc Natl Acad Sci USA. 82:1985;8780-8784.
21. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity. A hypothesis for the etiology of schizophrenia Neuroscience. 41:1991;1-24.
22. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology. 11:1994;245-256.
23. Halldin C., Farde L., Högberg T., Hall H., Ström P., Ohlberger A., Solin O. A comparative PET study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-. 2(receptor binding. Nucl Med Biol 18):1991;871-881.
24. Hartvig P., Torstenson R., Tedroff J., Watanabe Y., Fasth K.J., Bjurling P., Långström B. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography. J Neural Transm. 104:1997;329-339.
25. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
26. Heimer L., Alheid G.F. Piecing together the puzzle of basal forebrain anatomy. Napier T.C., Kalivas P.W., Hanin I. The Basal Forebrain. 1991;1-42 Plenum Press, New York.
27. Imperato A., Di Chiara G. Preferential stimulation of dopamine-release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther. 239:1986;219-228.
28. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol. 132:1986;337-338.
29. Jin H., George S.R., O'Dowd B.F. The significance of the CDC2 phosphorylation site in agonist-induced D1 dopamine receptor internalization. Soc Neurosci Abstr. 24:1998;598.
30. Johnson L.A., Pearlman G., Miller C.A., Young T.I., Thulborn K.R. MR quantification of cerebral ventricular volume using a semiautomated algorithm. AJNR. 14:1993;1373-1378.
31. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Gagher A., Jones T., Brooks D.J., Bench C.J., Grasby P.M. Evidence for striatal dopamine release during a video game. Nature. 393:1998;266-268.
32. 3H] Raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain Biochem Pharmacol. 34:1985;2251-2259.
33. Kuczenski R., Segal D. Differential effects of amphetamine and DA uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate DA and 3-methoxytyramine. J Pharmacol Exp Ther. 239:1992;219-228.
34. Kuczenski R., Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci. 9(6):1989;2051-2065.
35. 11C]raclopride studies. J Cereb Blood Flow Metab. 16(1):1996;42-52.
36. Laruelle M., Abi-Dargham A., Gil R., vanDyck C.H., D'Souza D., Rosenblatt W., Kruger S., McCance-Katz E., Brenner L., Zea-Ponce Y., Zoghbi S.S., Abi-Saab D., Fingado C., Baldwin R.M., Hoffer P.B., Krystal J., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects. Proc Natl Acad Sci USA. 93:1996;9235-9240.
37. Laruelle M., Iyer R.N., Al-Tikriti M.S., Zea-Ponce Y., Malison R., Zoghbi S.S., Baldwin R.M., Kung H.F., Charney D.S., Hoffer P.B., Innis R.B., Bradberry C.W. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse. 25:1997;1-14.
38. Links J.M., Zubieta J.K., Meltzer C.C., Stumpf M.J., Frost J.J. Influence of spatially heterogenous background activity on "hot object" quantitation in brain emission computed tomography. J Comput Assist Tomogr. 20(4):1996;680-687.
39. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 10:1990;740-747.
40. Logan J., Volkow N.D., Fowler J.S., Wang G.-J., Dewey Sl., MacGregor R., Schlyer D., Gatley S.J., Pappas N., King P., Hitzemann R., Vitkin S. Effects of blood flow on [11C]raclopride binding in the brain. Model simulations and kinetic analysis of PET data J Cereb Blood Flow Metab. 14:1994;995-1010.
41. Mazziotta J.C., Phelps M.E., Plummer D., Kuhl D.E. Quantitation in positron emission computed tomography. 5. Physical-anatomical effects. J Comput Assist Tomogr. 5:1981;734-743.
42. Meltzer CC, Kinahan PE, Greer PJ, Nichols TE, Comtat C, Cantwell MN, Lin MP, Price JC. Comparative evaluation of MR-based partial volume correction schemes for PET. J Nucl Med, in press.
43. Minoshima S., Berger K.L., Lee K.S., Mintun M.A. An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med. 33(8):1992;1579-1585.
44. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.R., Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 15:1984;217-227.
45. Pehek E.A., Schechter M.D., Yamamoto B.K. Effects of cathinone and amphetamine on the neurochemistry of of dopamine in vivo. Neuropharmacology. 29:1990;1171-1176.
46. Price J.C., Mason N.S., Lopresti B., Holt D., Simpson N.R., Drevets W., Smith G.S., Mathis C.A. PET measurement of endogenous neurotransmitter activity using high and low affinity radiotracers. Carson R., Daube-Witherspoon M., Herscovitch P. Quantitative Functional Brain Imaging with Positron Emission Tomography. 1998;441-448 Academic Press, San Diego.
47. Riche D., Hantraye P., Guibert B., Naquet R., Loc'h C., Maziere B., Maziere M. Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography. Brain Res Bull. 20:1988;283-301.
48. Richfield E.K., Young A.B., Penny J.B. Properties of D2 dopamine receptor autoradiography. High percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections Brain Res. 383:1986;121-128.
49. Robinson T.E., Camp D.M. Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats? Neuropsychopharmacology. 3:1990;163-173.
50. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci. 17(21):1997;8491-8497.
51. Ross S.B. Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J Neurochem. 56:1991;22-29.
52. 11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry. 154:1997;1209-1213.
53. 3H]raclopride. Implications for PET of the human brain Synapse. 3:1989;96-97.
54. Seeman P., Grigoriadis D. Dopamine receptors in brain and periphery. Neurochem Int. 10:1987;1-25.
55. Seeman P., Watanabe M., Grigoriadis D., Tedesco J.L., George S.R., Svensson U., Nilsson J.L.G., Neumeyer J.L. Dopamine D2 receptor binding sites for agonists. A tetrahedral model. Mol Pharmacol. 28:1986;391-399.
56. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577:1992;351-355.
57. Sharp T., Zetterstrom T., Ljungberg Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:1987;322-330.
58. Sibley D.R., De Lean A., Creese I. Anterior pituitary receptors. demonstration of interconvertible high and low affinity states of the D2 dopamine receptor J Biol Chem. 257:1982;6351-6361.
59. 11C-raclopride in normal human subjects. Neuropsychopharmacology. 18:1998;18-25. a.
60. 18F]altanserin in the human brain. Synapse. 30:1998;380-392. b.
61. Spinks T.J., Jones T., Bailey D.L., Townsend D.W., Grootoonk S., Bloomfield P.M., Gilardi M.C., Casey M.E., Sipe B., Reed J. Physical performance of a positron tomograph for brain imaging with retractable septa. Physics Med Biol. 37:1992;1637-1655.
62. Swerdlow N.R., Koob G.F. Dopamine, schizophrenia, mania, and depression. toward a unified hypothesis of cortico-striato-pallido-thalamic function Behav Brain Sci. 10:1987;197-245.
63. Townsend D.W., Isoardi R.A., Bendriem B. Volume imaging tomographs. Bendriem B., Townsend D.W. The Theory and Practice of 3D PET. 1998;133-167 Kluwer Academic Publishers, Boston.
64. 11C]raclopride in the human brain. Synapse. 16:1994;255-262.
65. Weiss F., Paulus M.P., Lorang M.T., Koob G.F. Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels. effects of acute and repeated administration J Neurosci. 12(11):1992;4372-4380.
66. Willner P. Dopaminergic mechanisms in depression and mania. Bloom F.E., Kupfer D.J. Psychopharmacology. The Fourth Generation of Progress:1995;921-932 Raven Press, New York.
67. Willner P., Ahlenius S., Muscat R., Scheel-Kruger J. The mesolimbic dopamine system. Willner P., Scheel-Kruger J. The Mesolimbic Dopamine System. From Motivation to Action:1991;615-638 Wiley, New York.
68. Wiseman M., Nichols T., Dachille M., Mintun M. Working towards an automatic and accurate method for PET-MRI alignment. J Nucl Med. 37(5):1996;224P.
69. Woods R.P., Masotho J., Cherry S.R. MRI-PET registration with automated algorithm. J Comput Assist Tomogr. 17:1993;536-546.